BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Pseudomonas infection
,
Hippocampus
,
Nosology
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TET2 protein
Summary
General Info
Curated Studies
Most Correlated Studies
Monocytic leukemia THP1 wildtype or TET2 knockout cells with or without IFNg treatment
Th1 and Th17 CD4+ T cells from spleens and lymph nodes of TET2 knockout mice
Pre B-cell and B-cell acute lymphoblastic leukemic cells with TET1 and TET2 double knockout
Hematopoietic stem cells from mice with TET2 and TET3 double knockout
Embryonic stem HUES-8 cells with TET1, TET2 and TET3 triple knockout
Explore Curated Studies Results
Literature
Most Relevant Literature
Tet2 acts in the lateral habenula to regulate social preference in mice.
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in peop…
Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and proge…
The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy.
Synthetic lethal targeting of TET2-mutant haematopoietic stem and progenitor cells by XPO1 inhibitor…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic A…
MIF Involvement in AML
Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia
Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ